To include your compound in the COVID-19 Resource Center, submit it here.

Building up nerve

How AxoSim is using its nerve-on-a-chip to screen compounds, model disease

AxoSim Technologies LLC has developed a 3-D human nerve-on-a-chip platform to recapitulate the in vivo organization of nerve bundles with greater fidelity to human systems than competitor models. The service provider is positioning its system both for preclinical neurotoxicity testing and modeling of diseases that affect axon tracts.

According to CEO Lowry Curley, the platform should be particularly useful for modeling peripheral neuropathy, demyelinating diseases like multiple sclerosis and

Read the full 686 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury


Article Purchase

This article may not be distributed to non-subscribers